US6 Burning mouth syndrome.

US6 Burning mouth syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

US6 Burning mouth syndrome. Abstract Text:

Jag Buchanan,

Burning mouth syndrome (BMS) is an idiopathic burning discomfort or pain affecting people with clinically normal oral mucosa in whom a medical or dental cause has been excluded. Associated symptoms include altered taste and a sensation of oral dryness. Terms previously used to describe BMS include glossodynia, glossopyrosis, stomatodynia, stomatopyrosis, sore tongue, and oral dysaesthesia. BMS mainly affects women particularly after the menopause, when its prevalence may be 18-33%. Suggested causal factors include hormonal disturbances associated with the menopause and psychogenic factors (including anxiety, depression, stress, life events, personality disorders, and cancer phobia). There is increasing evidence that a sensory neuropathy underlies BMS symptoms. Management of the symptoms of BMS can be challenging. It has been hampered by a relative lack of high quality evidence and randomised controlled trials into BMS treatment. Many studies have not differentiated between those with burning mouth syndrome (i.e. idiopathic disease) from those with other conditions (such as haematinic deficiencies) causing symptoms of a burning mouth, making results unreliable. Local and systemic factors (such as mucosal disorders, allergies, ill fitting dentures, hypersensitivity reactions and vitamin deficiencies) may cause the symptom of burning mouth and should be excluded before reaching the diagnosis of BMS. Various interventions have been proposed to be beneficial in managing BMS ranging from cognitive behaviour therapy, antidepressants, dietary supplements, hormone replacement in postmenopausal women, topical benzydamine hydrochloride, capsaician and clonazepam. This presentation will critically review BMS diagnosis, the evidence concerning the efficacy of potential interventions and propose a management protocol.

US6 Burning mouth syndrome. Publishing Authors By Initials

J Buchanan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

US6 Burning mouth syndrome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Oral diseases

VOLUME: 12 Suppl 1

Page Numbers: 4

Journal Abbreviation:

ISSN: 1354-523X

DAY: 25

MONTH: 08

YEAR: 2006

US6 Burning mouth syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9508565

US6 Burning mouth syndrome. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: US6 Burning mouth syndrome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for US6 Burning mouth syndrome.

AFFILIATION: Oral Medicine, Special Care Dentistry and Orofacial Pain; Eastman Dental Hospital, UCL, London, UK.

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Oral Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

US6 Burning mouth syndrome Related Publications

• An individualized psychosocial approach for "treatment resistant" behavioral symptoms of dementia among aged care residents.
• Autotransporter structure reveals intra-barrel cleavage followed by conformational changes.
• Behind the call center. Maximizing hospital call centers is not just a matter of goals, relationships and human interaction, it's about more efficient IT.
• Characterization of T wave alternans with ambulatory electrocardiography.
• Derivation and confirmation of scales measuring medical directors' attitudes about the hospitalization of nursing home residents.
• Do ACL-injured copers exhibit differences in knee kinematics?: An MRI study.
• Enzymatic synthesis of the methyl group of methionine. III. Spectral and electrophoretic studies of the prosthetic group of the B12 enzyme.
• Gastric inhibitory polypeptide (GIP) responses in type 2 diabetes using three different antibodies.
• Genetic diversity in a feral horse population from Sable Island, Canada.
• Genetics of gestational diabetes mellitus and type 2 diabetes.
• Laboratory markers of thrombosis risk in children with hereditary spherocytosis.
• Letter to the editor.
• Measuring adolescent functional health literacy: a pilot validation of the Test of Functional Health Literacy in Adults.
• Nestling testosterone controls begging behaviour in the pied flycatcher, Ficedula hypoleuca.
• Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date.
• Optimal pennation angle of the primary ankle plantar and dorsiflexors: variations with sex, contraction intensity, and limb.
• Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin.
• Retrieval of emotional memories.
• Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
• Role of protein O-mannosyltransferase Pmt4 in the morphogenesis and virulence of Cryptococcus neoformans.
• Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titre inhibitors.
• Sjögren's syndrome: History, clinical and pathological features.
• Spatial gradients in Clovis-age radiocarbon dates across North America suggest rapid colonization from the north.
• The courage of Galileo: Joseph Needham and the "germ warfare" allegations in the Korean War.
• The limits of proxy decisionmaking for incompetents.
• Thioredoxin: an unexpected meeting place.
• Tibialis anterior volumes and areas in ACL-injured limbs compared with unimpaired.
• To suspend or not to suspend: a randomised single blind trial of simple trapeziectomy versus trapeziectomy and flexor carpi radialis suspension.
• Tuning of the human left fusiform gyrus to sublexical orthographic structure.
• US6 Burning mouth syndrome.